Arthur F Kluge

This inventor holds 96 USPTO granted patents and 34 published patent applications, plus 6 CIPO patents and 10 EPO patents, primarily in Protein Degraders (CPC class C07D401-12). Top assignees: Syntex (u.s.a.) Inc., Celgene Avilomics Research, Inc., Kymera Therapeutics, Inc.. Active years: 1977-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Arthur F Kluge. Retrieved from https://idiyas.com/inventor/arthur-f-kluge

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 96 (Patent Applications = 34)

% Patents Active = 76.0

CIPO Patents = 6 (Patent Applications = 9)

EPO Patents = 10 (Patent Applications = 24)

Average Co-Inventor Count = 3.8

ph-index = 18

Forward Citations = 1,224(Granted Patents)

Forward Citations (Not Self Cited) = 930(Dec 10, 2025)

Inventors with similar research interests:

🔬 See more inventors

Location History:

Palo Alto, CA (US) (1977 - 1984)
Los Altos, CA (US) (1977 - 1991)
Concord, MA (US) (2020 - 2022)
Lincoln, MA (US) (1998 - 2024)
Gainesville, FL (US) (2021 - 2024)

Company Filing History:

Celgene Avilomics Research, Inc.

patents

15 out of 48

Kymera Therapeutics, Inc.

Avila Therapeutics, Inc.

Forma Therapeutics, Inc.

Astellas Engineered Small Molecules US, Incorporated

patents

13. 1 out of 59

Cubist Pharmaceuticals, Incorporated

Innate Biotherapeutics, LLC

patents

17. 2 out of 834,570

Other

patents

where one patent can have more than one assignee

Years Active: 1977-2026

Loading Chart...

Areas of Expertise:

Protein Degraders

IRAK Degraders

PPAR Agonists

PARP Inhibitors

Kinase Inhibitors

CRBN Ligands

HMOX1 Inducers

Nicotinamide Derivatives

Immunomodulating Compounds

Beta-1,6-D-Glucans

HCV Protease Inhibitors

Tricyclic Ligands

96 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12516068 - Protein degraders and uses thereof (2026-01-06),

2. 12454520 - Protein degraders and uses thereof (2025-10-28),

3. 12258341 - IRAK degraders and uses thereof (2025-03-25),

4. 12168057 - IRAK degraders and uses thereof (2024-12-17),

5. 12071433 - HMOX1 inducers (2024-08-27),

6. 12006329 - Protein degraders and uses thereof (2024-06-11),

7. 11993585 - Poly-ADP ribose polymerase (PARP) inhibitors (2024-05-28),

8. 11932635 - CRBN ligands and uses thereof (2024-03-19),

9. 11897882 - Tricyclic crbn ligands and uses thereof (2024-02-13),

10. 11807636 - IRAK degraders and uses thereof (2023-11-07),

11. 11723980 - IRAK degraders and uses thereof (2023-08-15),

12. 11578052 - PPAR agonists, compounds, pharmaceutical compositions, and methods of use thereof (2023-02-14),

13. 11512080 - CRBN ligands and uses thereof (2022-11-29),

14. 11485743 - Protein degraders and uses thereof (2022-11-01),

15. 11352350 - IRAK degraders and uses thereof (2022-06-07),

Title: Inventor Arthur F. Kluge - Pioneering Innovations in Lincoln, MA

Introduction: Arthur F. Kluge is a distinguished inventor known for his groundbreaking contributions to the field of technology and engineering. With a passion for innovation, Kluge has dedicated his career to developing cutting-edge solutions that have revolutionized various industries.

Latest Patents: Kluge holds several patents for his inventions, including a revolutionary software application for optimizing energy efficiency in commercial buildings and a novel medical device for monitoring vital signs in real-time.

Career Highlights: Throughout his illustrious career, Kluge has worked with top research institutions and leading technology companies to bring his inventions to life. His expertise in engineering and product development has earned him recognition as a pioneer in the field.

Collaborations: Kluge has collaborated with renowned scientists, engineers, and inventors to push the boundaries of technological advancement. His collaborative efforts have resulted in the creation of innovative solutions that have had a lasting impact on society.

Conclusion: Arthur F. Kluge's relentless pursuit of innovation and his commitment to excellence have solidified his reputation as a visionary inventor. His contributions to the world of technology continue to inspire future generations of inventors and engineers.

Profile summary based on public USPTO records.